| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
|
Hepatology
|
2008
|
2.36
|
|
2
|
Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.
|
Hepatology
|
2006
|
2.21
|
|
3
|
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
|
Gut
|
2012
|
2.17
|
|
4
|
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
|
Gastroenterology
|
2012
|
2.01
|
|
5
|
A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
|
Hepatology
|
2007
|
1.96
|
|
6
|
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis.
|
Hepatology
|
2012
|
1.92
|
|
7
|
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
|
Hepatology
|
2005
|
1.85
|
|
8
|
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.
|
Nat Genet
|
2013
|
1.83
|
|
9
|
Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome.
|
J Hepatol
|
2011
|
1.82
|
|
10
|
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.
|
J Hepatol
|
2003
|
1.68
|
|
11
|
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
|
Transplantation
|
2016
|
1.59
|
|
12
|
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients.
|
World J Gastroenterol
|
2006
|
1.58
|
|
13
|
Genetic factors of susceptibility and of severity in primary biliary cirrhosis.
|
J Hepatol
|
2008
|
1.56
|
|
14
|
Chronic liver injury during obstructive sleep apnea.
|
Hepatology
|
2005
|
1.39
|
|
15
|
[The liver and pregnancy].
|
Gastroenterol Clin Biol
|
2004
|
1.39
|
|
16
|
Pegylated interferon and ribavirin: A therapeutic option in patients who fail to respond to telaprevir-based triple therapy?
|
Hepatology
|
2013
|
1.38
|
|
17
|
Quality of life in patients with primary biliary cirrhosis.
|
Hepatology
|
2004
|
1.20
|
|
18
|
CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5.
|
Brain
|
2009
|
1.18
|
|
19
|
Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.
|
Am J Gastroenterol
|
2002
|
1.13
|
|
20
|
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.
|
BMC Cancer
|
2010
|
1.06
|
|
21
|
Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.
|
Clin Gastroenterol Hepatol
|
2007
|
1.05
|
|
22
|
Langerhans' cell histiocytosis of the liver in adults.
|
Clin Res Hepatol Gastroenterol
|
2011
|
1.02
|
|
23
|
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis.
|
J Hepatol
|
2010
|
1.01
|
|
24
|
Radiologic course of primary sclerosing cholangitis: assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression.
|
Hepatology
|
2013
|
0.99
|
|
25
|
Vascular involvement of the liver in Turner's syndrome.
|
Hepatology
|
2004
|
0.91
|
|
26
|
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
|
Liver Transpl
|
2011
|
0.91
|
|
27
|
[Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs].
|
Gastroenterol Clin Biol
|
2005
|
0.90
|
|
28
|
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirin.
|
J Hepatol
|
2012
|
0.87
|
|
29
|
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
|
Hepatology
|
2009
|
0.87
|
|
30
|
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis.
|
J Hepatol
|
2011
|
0.86
|
|
31
|
Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease.
|
Joint Bone Spine
|
2002
|
0.86
|
|
32
|
Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.
|
Hepatology
|
2013
|
0.85
|
|
33
|
Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
|
J Hepatol
|
2005
|
0.84
|
|
34
|
ABCB4 gene mutations and primary sclerosing cholangitis.
|
Gastroenterology
|
2004
|
0.84
|
|
35
|
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.
|
Liver Int
|
2011
|
0.81
|
|
36
|
Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
|
Eur J Gastroenterol Hepatol
|
2010
|
0.80
|
|
37
|
Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients.
|
Transplantation
|
2010
|
0.78
|
|
38
|
Primary biliary cirrhosis: proposal for a new simple histological scoring system.
|
Liver Int
|
2014
|
0.78
|
|
39
|
Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis.
|
J Hepatol
|
2002
|
0.78
|
|
40
|
Treatment of small hepatocellular carcinoma with acetic acid percutaneous injection.
|
Gastroenterol Clin Biol
|
2005
|
0.76
|
|
41
|
Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis.
|
Hepatology
|
2002
|
0.75
|
|
42
|
Primary sclerosing cholangitis and biliary malignancy: a glimmer of hope?
|
J Hepatol
|
2004
|
0.75
|
|
43
|
Schistosoma mansoni infection and liver graft.
|
Transplantation
|
2005
|
0.75
|
|
44
|
Combination therapy of chronic viral hepatitis B with lamivudine and interferon: better than what?
|
J Hepatol
|
2002
|
0.75
|
|
45
|
[Risks and precautions for the use of lamivudine in patients with chronic hepatitis B virus infection].
|
Gastroenterol Clin Biol
|
2002
|
0.75
|
|
46
|
Overlap Syndromes.
|
Dig Dis
|
2015
|
0.75
|
|
47
|
Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
|
Ann Surg
|
2017
|
0.75
|
|
48
|
[Primary biliary cirrhosis--autoimmune hepatitis overlap syndrome: middle age?].
|
Gastroenterol Clin Biol
|
2007
|
0.75
|